
|Videos|August 21, 2020
2020 vision: The future of ophthalmology (Part II)
Author(s)Alex Delaney-Gesing , David Hutton
In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.
Advertisement
Alice Epitropoulos, MD, FACS (Cataract and Refractive Center of Ohio), and Dee Stephenson, MD, FACS (president, American Board of Eye Surgery), speak with Ophthalmology Times'® David Hutton on how the use of telemedicine for patient care during the coronavirus pandemic may be the new norm, what's in the lens pipeline, as well as how the expectation versus reality for 2020 in the ophthalmic space have compared.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: What’s in the glaucoma treatment pipeline?
2
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
3
Moorfields study reveals sharp rise in glaucoma burden across the UK
4
Why individualized glaucoma care remains essential amid uneven patient awareness
5



























